Expert warns: Anti-acidity meds tied to elevated migraine risk
Published By : Bratati Baral | May 6, 2024 11:12 AM
Share
New Delhi, May 6: Taking acid reflux medications may raise the risk of migraines in individuals already suffering from the debilitating headache, according to a top neurologist.
Dr Sudhir Kumar from Indraprastha Apollo Hospitals, said this, citing a recent study published in the journal Neurology Clinical Practice.
Led by researchers from the University of Maryland in the US, the study showed that acid-reducing drugs, including proton pump inhibitors (PPIs) such as omeprazole and esomeprazole, histamine H2-receptor antagonists (H2RAs), H2 blockers such as cimetidine and famotidine, and antacid supplements, are linked to a higher risk of migraines and other severe headaches than people who do not take these medications.
“In people who are suffering from migraines or other severe headaches, and are taking PPIs or H2RAs for treating gastrointestinal symptoms, it may be worthwhile stopping these medicines to see if their headaches reduce,” the doctor wrote in a post on X.
The study found that PPIs use was associated with a 70 per cent higher risk of migraines and other headaches, while H2RAs use was associated with a 40 per cent higher risk.
“It is possible that these observed associations are related to comorbidity between gastrointestinal (GI) conditions and migraine disease and symptoms, Dr Sudhir explained.
He noted that several studies have observed associations between the presence of migraine and GI conditions, including Helicobacter pylori infection, irritable bowel syndrome, celiac disease, peptic ulcers, gastroparesis, and GERD.
“New cases of migraine have been noted after starting PPI/H2RA therapy. Therefore, further studies are needed to establish the cause-effect relationship,” Dr Sudhir said.
Prameya English Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Odisha: 10 hospitalized after eating wild mushroom curry in Rayagada’s village
SUM Hospital launches free Cy-Tb test
Odisha health department set for joint drive against water & vector borne diseases
Determined to saw off every drug cartel and protect our youth: Amit Shah
COVID-19 vaccines not linked to surge in heart attack deaths: Health Ministry
Odisha: Youth lead the way in ‘Menstrual Health Awareness’ at Berhampur University
AIIMS Bhubaneswar ranked 2nd best emerging medical college in India
Health Minister reviews Dengue, Malaria, Diarrhea, and Jaundice, orders for proactive measures
Diarrhea outbreak in Odisha under control: Health Minister
Food Safety Crackdown in Bhuban: Stalls Sealed and Fined Amid Public Health Crisis
International Yoga Day 2025: History and significance
OMC Launches Major Sickle Cell Anemia Awareness Drive in Odisha's Mining Belts
Diarrhea outbreak in Jajpur triggers panic; Six hotels sealed
Odisha: Expert teams deployed to tackle Diarrhoea outbreak in three districts
Odisha: Health Minister reviews Diarrhoea outbreak, urges rapid action
Odisha battles Diarrhoea outbreak; Minister Suraj Suryavanshi reviews situation in Jajpur
AIIMS Bhubaneswar to be accorded Centre of Excellence Status for Sickle Cell Disease Management
"From Research to Practice": GSICON 2025 Aims to Revolutionize Geriatric Medicine in India
Odisha Govt intensifies diarrhea prevention measures across five districts
Orissa High Court halts Asst. Prof Recruitment at AHPGIC Cuttack citing irregularity